March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Transforming Growth Factor-β Promotes Rho G-protein Mediated Synthesis and Secretion of Endothelin-1 in Human Trabecular Meshwork Cells
Author Affiliations & Notes
  • Cynthia L. von Zee
    Research Service (151), Edward Hines, Jr. VA Hospital, Hines, Illinois
  • Kelly A. Langert
    Program of Neuroscience,
    Loyola University Chicago, Maywood, Illinois
  • Evan B. Stubbs, Jr.
    Research Service (151), Edward Hines, Jr. VA Hospital, Hines, Illinois
    Ophthalmology,
    Loyola University Chicago, Maywood, Illinois
  • Footnotes
    Commercial Relationships  Cynthia L. von Zee, None; Kelly A. Langert, None; Evan B. Stubbs, Jr., None
  • Footnotes
    Support  Department of Veterans Affairs (C3638R, B3756-F, C7506M), the Illinois Society for the Prevention of Blindness, the Midwest Eye Banks, and the Richard A. Peritt Charitable Foundation
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3239. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cynthia L. von Zee, Kelly A. Langert, Evan B. Stubbs, Jr.; Transforming Growth Factor-β Promotes Rho G-protein Mediated Synthesis and Secretion of Endothelin-1 in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3239.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Analysis of aqueous humor from patients with primary open-angle glaucoma reveal marked and potentially pathologic increases in the content of endothelin-1 (ET-1) and transforming growth factor-beta (TGF-β). Here, we determined the consequences of TGF-β signaling on regulation of ET-1 expression and secretion by human trabecular meshwork (TM) cells.

Methods: : Human TM cell lines (NTM5 and GTM3) cultured in serum-free media were incubated in the absence or presence of TGF-β1 or -β2, and relative changes in preproendothelin (ppET)-1 mRNA content and secreted mature ET-1 peptide were quantified by real-time PCR (qRT-PCR) and ELISA, respectively. In some experiments, TGF-β or ET-1 receptor antagonists, or inhibitors of Rho G-protein activation, were evaluated for effects on TGF-β signaling. Filamentous actin (F-actin) organization was visualized by AlexaFluor488-conjugated phalloidin.

Results: : Human TM cells cultured in the presence (5 ng/ml, 24h) of TGF-β1 or TGF-β2 exhibit a marked (>9-fold) increase in ppET-1 mRNA content compared with vehicle-treated controls. Co-incubation with SB-505124, a selective inhibitor of TGFβRI/ALK-5 signaling, prevented TGF-β mediated ppET-1 mRNA expression. In contrast, co-incubation with ETA (BQ-123) or ETB (BQ-788) receptor antagonists had no effect on TGF-β mediated ppET-1 mRNA expression. TGF-β elicited a robust (>7-fold) biphasic secretion of mature ET-1 from TM cells while functionally enhancing F-actin stress fiber organization. Inhibition of Rho signaling significantly attenuated TGF-β mediated increases in ppET-1 mRNA content, secretion of mature ET-1, and F-actin stress fiber assembly.

Conclusions: : TGF-β, signaling through the TGFβRI/ALK-5 receptor, elicits marked increases in ET-1 mRNA content and ET-1 secretion from cultured human TM cells. Elevated levels of TGF-β2 present in AH of POAG patients may elevate IOP, in part, by eliciting aberrant Rho G-protein dependent cell contraction, and increasing ET-1 synthesis and secretion, in human TM cells.

Keywords: trabecular meshwork • cytokines/chemokines • cytoskeleton 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×